Deutsche Bank is out with its report today on DaVita DVA, raising its PT from $101 to $102.
In a note to clients, Deutsche Bank writes, "As a somewhat belated follow up to Q1 results, we are introducing an updated model. While we've made some changes to assumptions which result in a 3% revision to 2012 EPS, our forecasts remain considerably higher than consensus and the guidance recently provided by mgmt (led by CEO Kent Thiry or 'KT'). A number of changes are fine-tuning, but fundamentally we are 10% above consensus for 2012 because we believe there will be add'l cost/tx opportunities over the next year. Reiterate Buy / $102 (from $101) price target on solid outlook."
Shares of DVA closed Thursday at $86.62, up 1.01% from Wednesday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorPrice TargetAnalyst RatingsDavitaDeutsche BankHealth CareHealth Care Services
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in